Skip to main content
OpenTrials

Clinical trial condition

Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor

Explore clinical trials studying Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor trial results

Completed

Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer

NCT00551070

Conditions
Adenocarcinoma, Borderline Ovarian Serous Tumor, Carcinoma, +11 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Hartford Hospital Hartford, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
View all 49 locations
View Trial Details
Completed

Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors

NCT00301756

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • Odette Cancer Centre- Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
  • University Health Network Princess Margaret Cancer Center P2C Toronto, Ontario, Canada
  • University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
View Trial Details

Related conditions